Back to List View Graph View

MIR21

MIR21 encodes microRNA-21 (miR-21), a small non-coding RNA that functions as a post-transcriptional regulator of gene expression.

Where the papers sit

14 papers from the last 6 months study MIR21 directly · updated from PubMed 15 Nov 2026

Study type 0 clinical trials · 12 human data · 2 preclinical

Themes 3 themes · 1 new direction

  • miRNA Cancer Detection

    Ultrasensitive miRNA detection is moving toward multiplex, amplification-assisted CRISPR and nanomaterial biosensors for cancer screening and monitoring. Cas12a, CRISPR editing, G-quadruplexes, nanozymes, DNA walkers and catalytic hairpin circuits recur, with bladder cancer a frequent application. Platforms target low detection limits in urine or other clinical samples and increasingly seek label-free, colorimetric or portable readouts. The biological effect of miR-21 editing is represented, but the cluster mainly addresses analytical detection rather than treatment.

    9 papers · 64.3%

  • Multiplex Cancer miRNA Detection

    Cancer miRNA testing is moving toward rapid, multiplex visual assays that combine logic gating with nanoparticle signal generation. Gold nanoparticles, DNA self-assembly and AND gates are used to require concurrent biomarkers, including MIR155 and miR-21, to improve diagnostic specificity. Breast cancer and hepatocellular carcinoma provide the main application contexts, with colorimetric and lateral-flow formats favoring accessible readouts. The work remains at assay-development stage, so clinical discrimination and prospective validation are unresolved.

    3 papers · 21.4%

  • Intracellular miRNA Imaging

    Intracellular miRNA imaging is being refined toward higher specificity and lower background rather than bulk measurement. Cas13a and DNA circuits use dual-key or endogenous APE1 activation to constrain fluorescence to miRNA-positive living cells. Free-amplified or autocatalytic signal generation aims to improve signal-to-noise and spatial precision. The small set supports proof-of-concept imaging, while clinical validation and quantitative performance in tissue remain open.

    2 papers · 14.3%

NEW DIRECTION

miR-21 is treated as an editable causal target in urothelial carcinoma rather than merely as a detectable biomarker or drug-responsive pathway component

CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells 42319574Jun moves miR-21 beyond the set's usual roles as a cancer-associated analyte in diagnostic assays or as an expression change associated with pharmacologic treatment. By directly editing miR-21 and examining the resulting biological effects, the study treats it as a manipulable causal target in tumor cells, opening a gene-editing direction rather than another application of biomarker detection or pathway modulation.

Papers

The 14 papers from the last 6 months that study MIR21 directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

miRNA Cancer Detection (9)
  1. A cascaded signal amplification strategy combining Au@Cu2O core-shell nanozymes and CRISPR-Cas12a self-cycling for ultrasensitive colorimetric detection of miRNA-21. Analytica chimica acta · 6 Sept 2026 PMID 42702425
  2. A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection. ACS applied materials & interfaces · 2 Sept 2026 PMID 42682078
  3. A hydrogel microsphere-based catalytic hairpin assembly for simple miRNA detection. Analytical methods : advancing methods and applications · 1 Sept 2026 PMID 42676189
  4. Nucleic acid probe-functionalized self-powered sensor for detection of biomarkers in clinical urine samples. Science advances · 5 Aug 2026 PMID 42555722
  5. Topology-Gated λ Exonuclease Enables Amplification-Free Signal Boosting. Journal of the American Chemical Society · 21 Jul 2026 PMID 42479891
  6. Compartmentalization-inspired dual-chamber CRISPR sensing coupled with single-atom electrocatalysis for crosstalk-free multiplex microRNA detection. Biosensors & bioelectronics · 9 Jul 2026 PMID 42424999
  7. Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical chemistry · 9 Jul 2026 PMID 42424186
  8. CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular biology reports · 19 Jun 2026 PMID 42319574
  9. Dual MicroRNA Simultaneous One-Step Profiling via Filler-Mediated Quantum Dot DNA Nanospheres for Bladder Cancer Screening. ACS nano · 13 Jun 2026 PMID 42287261
Multiplex Cancer miRNA Detection (3)
  1. A lateral flow assay strip based on AND logic gate and DNA self-assembly for dual miRNA detection in breast cancer diagnosis. Mikrochimica acta · 4 Aug 2026 PMID 42550284
  2. Modular CRISPR-Cas12a-Activated Gold Nanoparticle Assay for Rapid Visual Detection of Hepatocellular Carcinoma-Related miRNAs. ACS sensors · 9 Jun 2026 PMID 42263201
  3. Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica chimica acta · 1 Jun 2026 PMID 42219637
Intracellular miRNA Imaging (2)
  1. A double-key responsive TDNs-HC/Cas13a DNA circuit for free-amplified detection and precise imaging of miRNAs in living cell. Analytica chimica acta · 19 Sept 2026 PMID 42763165
  2. Autocatalytic DNA nanosphere assembly activated by endogenous APE1 for intracellular miR-21 imaging. Analytica chimica acta · 7 Aug 2026 PMID 42567595

By study type

Human data, design not indexed (12)
  1. A double-key responsive TDNs-HC/Cas13a DNA circuit for free-amplified detection and precise imaging of miRNAs in living cell. Analytica chimica acta · 19 Sept 2026 PMID 42763165
  2. A cascaded signal amplification strategy combining Au@Cu2O core-shell nanozymes and CRISPR-Cas12a self-cycling for ultrasensitive colorimetric detection of miRNA-21. Analytica chimica acta · 6 Sept 2026 PMID 42702425
  3. A Dual-Mode Fluorescent and Colorimetric Biosensor Based on AuNPs@RCA Nanogel-Integrated Multipedal DNA Walker for Ultrasensitive miRNA Detection. ACS applied materials & interfaces · 2 Sept 2026 PMID 42682078
  4. A hydrogel microsphere-based catalytic hairpin assembly for simple miRNA detection. Analytical methods : advancing methods and applications · 1 Sept 2026 PMID 42676189
  5. Autocatalytic DNA nanosphere assembly activated by endogenous APE1 for intracellular miR-21 imaging. Analytica chimica acta · 7 Aug 2026 PMID 42567595
  6. Nucleic acid probe-functionalized self-powered sensor for detection of biomarkers in clinical urine samples. Science advances · 5 Aug 2026 PMID 42555722
  7. A lateral flow assay strip based on AND logic gate and DNA self-assembly for dual miRNA detection in breast cancer diagnosis. Mikrochimica acta · 4 Aug 2026 PMID 42550284
  8. Topology-Gated λ Exonuclease Enables Amplification-Free Signal Boosting. Journal of the American Chemical Society · 21 Jul 2026 PMID 42479891
  9. Compartmentalization-inspired dual-chamber CRISPR sensing coupled with single-atom electrocatalysis for crosstalk-free multiplex microRNA detection. Biosensors & bioelectronics · 9 Jul 2026 PMID 42424999
  10. Dual MicroRNA Simultaneous One-Step Profiling via Filler-Mediated Quantum Dot DNA Nanospheres for Bladder Cancer Screening. ACS nano · 13 Jun 2026 PMID 42287261
  11. Modular CRISPR-Cas12a-Activated Gold Nanoparticle Assay for Rapid Visual Detection of Hepatocellular Carcinoma-Related miRNAs. ACS sensors · 9 Jun 2026 PMID 42263201
  12. Design and fabrication of a dual-mode colorimetric nanobiosensor for detection of breast cancer-related microRNA biomarkers upon the simultaneous application of gold nanoparticles and DNAzyme. Analytica chimica acta · 1 Jun 2026 PMID 42219637
Preclinical: animal, cell and lab studies (2)
  1. Pan-Cancer Liquid Biopsy and Treatment Monitoring via a Split crRNA-Activated Label-Free CRISPR/Cas12a Platform for Ultrasensitive MicroRNA Detection. Analytical chemistry · 9 Jul 2026 PMID 42424186
  2. CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. Molecular biology reports · 19 Jun 2026 PMID 42319574